目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS AND REGIONS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.5.1 METHODOLOGY-RELATED LIMITATIONS
1.5.2 SCOPE-RELATED LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of secondary sources
2.1.2 PRIMARY DATA SOURCES
2.1.2.1 List of key primary stakeholders interviewed
2.1.2.2 Insights from primary experts
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 GROWTH RATE ASSUMPTIONS
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 RESEARCH ASSUMPTIONS
2.5.1 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SURGICAL IMAGING MARKET
4.2 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT
4.3 SURGICAL IMAGING MARKET, BY KEY COUNTRY/REGION
4.4 REGIONAL MIX: SURGICAL IMAGING MARKET
4.5 SURGICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in surgical imaging modalities
5.2.1.2 Rising demand for minimally invasive surgeries
5.2.1.3 Technological transition to flat-panel detectors and hybrid operating rooms
5.2.1.4 Expanding applications across surgical specialties
5.2.2 RESTRAINTS
5.2.2.1 High equipment costs of surgical imaging systems
5.2.2.2 Interoperability challenges with existing hospital systems
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing number of surgical procedures conducted in ASCs (ambulatory surgical centers)
5.2.3.2 Development of hybrid operating rooms (ORs)
5.2.3.3 Growing demand for data-integrated imaging systems
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled workforce
5.2.4.2 Imaging obese patients
5.2.4.3 Hospital budget cuts
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 INDUSTRY TRENDS
5.4.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE AND ADVANCED ANALYTICS
5.4.2 AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN SURGERY
5.4.3 GROWTH OF HYBRID OPERATING ROOMS AND MULTIMODAL IMAGING
5.4.4 COMPACT, MOBILE, AND LOW-DOSE IMAGING TECHNOLOGIES
5.4.5 INTEGRATION WITH SURGICAL ROBOTICS AND ADVANCED 3D/4D IMAGING
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY TYPE
5.5.2 AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY KEY PLAYER
5.5.3 PRICING MODELS
5.6 VALUE CHAIN ANALYSIS
5.6.1 RESEARCH & DEVELOPMENT
5.6.2 MANUFACTURING & ASSEMBLY
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.7 SUPPLY CHAIN ANALYSIS
5.7.1 PROMINENT COMPANIES
5.7.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.7.3 END USERS
5.8 ECOSYSTEM ANALYSIS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Intraoperative imaging systems
5.10.1.2 Image-guided surgery and navigation systems
5.10.2 COMPLEMENTARY TECHNOLOGIES
5.10.2.1 Radiopharmaceutical development and theranostics
5.10.2.2 Advanced computing and big data analytics
5.10.3 ADJACENT TECHNOLOGIES
5.10.3.1 Endoscopic & laparoscopic imaging systems
5.10.3.2 AI/Image analytics solutions
5.11 PATENT ANALYSIS
5.12 TRADE ANALYSIS
5.12.1 IMPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022)
5.12.2 EXPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022)
5.13 KEY CONFERENCES AND EVENTS, 2025-2026
5.14 CASE STUDY ANALYSIS
5.14.1 ADVANCING ENDOSCOPIC SINUS AND SKULL BASE SURGERY WITH SURGICAL NAVIGATION AT GMCH-32
5.14.2 PRECISION MAXILLOFACIAL SURGERY THROUGH BRAINLAB'S INTRAOPERATIVE NAVIGATION AND CT INTEGRATION
5.14.3 AI-POWERED REAL-TIME TUMOR MARGIN DETECTION IN SKULL BASE SURGERY WITH STIMULATED RAMAN HISTOLOGY
5.15 TARIFF AND REGULATORY LANDSCAPE
5.15.1 TARIFF DATA FOR HS CODE 9022
5.15.2 REGULATORY LANDSCAPE
5.15.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15.4 REGULATORY TRENDS
5.15.4.1 North America
5.15.4.1.1 US
5.15.4.1.2 Canada
5.15.5 EUROPE
5.15.6 ASIA PACIFIC
5.15.6.1 Japan
5.15.6.2 China
5.15.6.3 India
5.15.6.4 Middle East (GCC Region)
5.15.6.4.1 UAE
5.15.6.4.2 Saudi Arabia
5.15.6.5 Africa
5.16 REIMBURSEMENT SCENARIO ANALYSIS
5.17 PORTER'S FIVE FORCES ANALYSIS
5.17.1 BARGAINING POWER OF SUPPLIERS
5.17.2 BARGAINING POWER OF BUYERS
5.17.3 THREAT OF NEW ENTRANTS
5.17.4 THREAT OF SUBSTITUTES
5.17.5 INTENSITY OF COMPETITIVE RIVALRY
5.18 KEY STAKEHOLDERS AND BUYING CRITERIA
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.18.2 BUYING CRITERIA
5.19 UNMET NEEDS ANALYSIS
5.19.1 CURRENT UNMET NEEDS
5.19.2 END-USER EXPECTATIONS
5.20 BUSINESS MODEL
5.20.1 CAPITAL EQUIPMENT SALES MODEL
5.20.2 SUBSCRIPTION AND SAAS MODEL
5.20.3 PAY-PER-USE/TRANSACTION-BASED MODEL
5.20.4 MANAGED SERVICES MODEL
5.20.5 VALUE-BASED/OUTCOME-DRIVEN MODEL
5.20.6 HYBRID MODEL (BUNDLED HARDWARE + DIGITAL SERVICES)
5.21 IMPACT OF AI/GEN AI ON SURGICAL IMAGING MARKET
5.21.1 INTRODUCTION
5.21.2 MARKET POTENTIAL OF AI/GEN AI IN SURGICAL IMAGING MARKET
5.21.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
5.21.3.1 AI-assisted intraoperative imaging for enhanced detection of peritoneal metastases
5.21.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.21.4.1 Surgical navigation & visualization software
5.21.4.2 Operating room integration platforms
5.21.4.3 Intraoperative imaging systems (CT, MRI, fluoroscopy, ultrasound)
5.21.5 USER READINESS AND IMPACT ASSESSMENT
5.21.5.1 User readiness
5.21.5.1.1 User A: Hospitals
5.21.5.1.2 User B: Ambulatory surgical clinics (ASCs)
5.21.5.2 Impact assessment
5.21.5.2.1 User A: Hospitals
5.21.5.2.1.1 Implementation
5.21.5.2.1.2 Impact
5.21.5.2.2 User B: Ambulatory surgical clinics (ASCs)
5.21.5.2.2.1 Implementation
5.21.5.2.2.2 Impact
5.22 IMPACT OF 2025 US TARIFF - OVERVIEW
5.22.1 INTRODUCTION
5.22.2 KEY TARIFF RATES
5.22.3 PRICE IMPACT ANALYSIS
5.22.4 IMPACT ON COUNTRY/REGION
5.22.4.1 US
5.22.4.2 EUROPE
5.22.4.3 ASIA PACIFIC
5.22.5 IMPACT ON END-USE INDUSTRIES
5.22.6 CONCLUSION

6 SURGICAL IMAGING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 C-ARMS
6.2.1 C-ARMS ENHANCING SURGICAL OUTCOMES THROUGH REAL-TIME FLUOROSCOPIC IMAGING TO DRIVE MARKET
6.3 CT SCANNERS
6.3.1 ENHANCED OPERATIVE CARE WITH HIGH-ACCURACY INTRAOPERATIVE IMAGING TO DRIVE ADOPTION OF CT SCANNERS
6.4 ULTRASOUND SYSTEMS
6.4.1 ULTRASOUND ADVANCING SURGICAL PRECISION THROUGH REAL-TIME INTRAOPERATIVE IMAGING TO DRIVE SEGMENTAL GROWTH
6.5 INTEGRATED MR-OR SYSTEMS
6.5.1 INTEGRATED MR OR SYSTEMS DRIVING SURGICAL ACCURACY THROUGH REAL-TIME SOFT TISSUE IMAGING
6.6 SURGICAL NAVIGATION SOFTWARE
6.6.1 GROWING USE OF SURGICAL NAVIGATION SOFTWARE DRIVING OPERATIVE PRECISION WITH REAL-TIME GUIDANCE
6.7 ACCESSORIES
6.7.1 INCREASING ADOPTION OF SURGICAL IMAGING ACCESSORIES TO DRIVE ENHANCED VISUALIZATION AND WORKFLOW EFFICIENCY

7 SURGICAL IMAGING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PROCEDURE TYPE
7.2.1 MINIMALLY INVASIVE SURGERY
7.2.1.1 Rising adoption of minimally invasive techniques driving precision and faster recovery in surgical imaging
7.2.2 LAPAROSCOPY
7.2.2.1 Enhanced precision and faster recovery driving increased adoption of laparoscopic imaging
7.2.3 ENDOSCOPY
7.2.3.1 Real-time internal visualization driving growth in endoscopic imaging
7.2.4 OTHER PROCEDURES
7.3 SURGERY TYPE
7.3.1 GENERAL SURGERY
7.3.1.1 Enhanced visualization transforming general surgical procedures to fuel growth
7.3.2 CARDIOVASCULAR SURGERY
7.3.2.1 Advanced imaging techniques enhancing cardiovascular interventions to fuel growth
7.3.3 OB/GYN SURGERY
7.3.3.1 Growing use of imaging-guided precision driving improved surgical outcomes in OB/GYN procedures
7.3.4 ORTHOPEDIC & MUSCULOSKELETAL SURGERY
7.3.4.1 Adoption of imaging solutions driving optimized implant placement and bone alignment
7.3.5 NEUROSURGERY
7.3.5.1 High-precision imaging navigating complex neural procedures to drive market
7.3.6 UROLOGY SURGERY
7.3.6.1 Imaging-guided precision improving outcomes in urological surgeries to drive demand
7.3.7 OTHER SURGERIES

8 SURGICAL IMAGING MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & SURGICAL CENTERS
8.2.1 RISING SURGICAL VOLUMES IN HOSPITALS AND SURGICAL CENTERS TO DRIVE MARKET
8.3 SPECIALTY CLINICS
8.3.1 SPECIALTY CLINICS DRIVING SURGICAL IMAGING ADOPTION THROUGH PRECISION AND EFFICIENCY
8.4 AMBULATORY SURGICAL CENTERS
8.4.1 AMBULATORY SURGICAL CENTERS DRIVING SURGICAL IMAGING ADOPTION FOR EFFICIENT OUTPATIENT CARE
8.5 OTHER END USERS

9 SURGICAL IMAGING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 Advancements in AI and augmented reality integration in surgery to drive market
9.2.3 CANADA
9.2.3.1 Collaborations between national AI institutes and health systems to drive market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Precision-driven imaging and expanding hospital capacity to drive regional growth
9.3.3 UK
9.3.3.1 NHS-led integration of surgical imaging and skilled workforce strength to drive regional growth
9.3.4 FRANCE
9.3.4.1 Steady growth in radiology workforce supporting imaging expansion
9.3.5 ITALY
9.3.5.1 Balancing imaging modernization with workforce shortages
9.3.6 SPAIN
9.3.6.1 Expanding surgical imaging access with focus on regional equity
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Enhancing surgical outcomes with innovative imaging technologies
9.4.3 CHINA
9.4.3.1 Strong network of grade-A tertiary hospitals driving advanced imaging adoption
9.4.4 INDIA
9.4.4.1 Government initiatives and private hospital collaborations to fuel growth
9.4.5 SOUTH KOREA
9.4.5.1 Rising aging population driving demand for precision surgical imaging
9.4.6 AUSTRALIA
9.4.6.1 Strengthening surgical imaging capabilities for minimally invasive procedures
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Government and private investment in surgical infrastructure to drive market
9.5.3 MEXICO
9.5.3.1 Accelerating minimally invasive and AI-enabled surgical imaging to drive market
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Rising healthcare demand and innovation driving surgical imaging advancements
9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL IMAGING MARKET
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Application (procedure type) footprint
10.5.5.5 Application (surgery type) footprint
10.5.5.6 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of emerging players/startups
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 GE HEALTHCARE
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches & approvals
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 SIEMENS HEALTHINEERS AG
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches & approvals
11.1.2.3.2 Deals
11.1.2.3.3 Other developments
11.1.2.3.4 Expansions
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 KONINKLIJKE PHILIPS N.V.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches & approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 SHIMADZU CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches & approvals
11.1.4.3.2 Deals
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 FUJIFILM HOLDINGS CORPORATION
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches & approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 ZIEHM IMAGING GMBH
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches & approvals
11.1.6.3.2 Deals
11.1.7 HOLOGIC, INC.
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Deals
11.1.8 SMITH+NEPHEW
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches & approvals
11.1.8.3.2 Deals
11.1.9 MEDTRONIC
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches & approvals
11.1.9.3.2 Deals
11.1.10 STRYKER
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Product launches & approvals
11.1.10.3.2 Deals
11.1.11 CANON MEDICAL SYSTEMS CORPORATION
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches & approvals
11.1.11.3.2 Deals
11.1.12 OLYMPUS CORPORATION
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.12.3.1 PRODUCT LAUNCHES AND APPROVALS
11.1.12.3.2 Deals
11.1.12.3.3 Expansions
11.1.13 NOVANTA INC.
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.3.1 Deals
11.1.14 GLOBUS MEDICAL
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.14.3.1 Product launches & approvals
11.1.14.3.2 Deals
11.1.15 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.15.3.1 Product launches & approvals
11.1.16 SONY ELECTRONICS INC.
11.1.16.1 Business overview
11.1.16.2 Products offered
11.1.16.3 Recent developments
11.1.16.3.1 Product launches & approvals
11.1.16.3.2 Deals
11.1.17 UNITED IMAGING HEALTHCARE CO., LTD.
11.1.17.1 Business overview
11.1.17.2 Products offered
11.1.17.3 Recent developments
11.1.17.3.1 Product launches & approvals
11.1.18 BARCO
11.1.18.1 Business overview
11.1.18.2 Products offered
11.1.18.3 Recent developments
11.1.18.3.1 Product launches & approvals
11.1.18.3.2 Deals
11.1.19 AUXEIN
11.1.19.1 Business overview
11.1.19.2 Products offered
11.1.19.3 Recent developments
11.1.19.3.1 Product launches & approvals
11.1.20 BRAINLAB SE
11.1.20.1 Business overview
11.1.20.2 Products offered
11.1.20.3 Recent developments
11.1.20.3.1 Deals
11.2 OTHER PLAYERS
11.2.1 TRIVITRON HEALTHCARE
11.2.2 RGS HEALTHCARE
11.2.3 GEMSS HEALTHCARE CO., LTD.
11.2.4 SKANRAY TECHNOLOGIES LIMITED
11.2.5 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
11.2.6 ARTHREX, INC.

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS